138 related articles for article (PubMed ID: 7756580)
1. The use of a totally human monoclonal antibody for the staining of primary and metastatic human breast tumors.
Strelkauskas AJ; Welsh J; Metcalf JS; Aldenderfer PH
Hum Antibodies Hybridomas; 1994; 5(3-4):157-64. PubMed ID: 7756580
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
Beketić-Oresković L; Sarcević B; Malenica B; Novak D
Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
[TBL] [Abstract][Full Text] [Related]
3. Morphologic assessment of reactivity to monoclonal antibodies generated against breast cancer cells in mammary tissues removed for clinical dysplasia or cancer.
Nuti M; Castagna M; Squartini F
Appl Pathol; 1984; 2(3):117-27. PubMed ID: 6085790
[TBL] [Abstract][Full Text] [Related]
4. Patterns of reaction of monoclonal antibodies HMFG-1 and -2 with benign breast tissues and breast carcinomas.
Taylor-Papadimitriou J; Millis R; Burchell J; Nash R; Pang L; Gilbert J
J Exp Pathol; 1986; 2(4):247-60. PubMed ID: 2431118
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of prostate carcinoma-associated antigens.
Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody (AB/3) reactive with human breast cancer.
Iacobelli S; Natoli V; Scambia G; Santeusanio G; Negrini R; Natoli C
Cancer Res; 1985 Sep; 45(9):4334-8. PubMed ID: 3896478
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody 5C3 raised against formalin fixed paraffin-embedded invasive breast tumour tissue: characterisation of its reactive antigen via immunoprecipitation and internal sequencing.
Larkin A; Moran E; Kennedy SM; Clynes M
J Immunol Methods; 2005 Aug; 303(1-2):53-65. PubMed ID: 16038928
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations.
Mariani-Costantini R; Barbanti P; Colnaghi MI; Ménard S; Clemente C; Rilke F
Am J Pathol; 1984 Apr; 115(1):47-56. PubMed ID: 6711680
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal antibody JDB1 reacts with cytoplasmic and membrane bound antigens present on a variety of human breast tumor cell lines.
Strelkauskas AJ; Aldenderfer PH; Warner GA
Hum Antibodies Hybridomas; 1991 Oct; 2(4):207-14. PubMed ID: 1751783
[TBL] [Abstract][Full Text] [Related]
10. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
11. Generation and immunohistological characterization of human monoclonal antibodies to mammary carcinoma cells.
Imam A; Drushella MM; Taylor CR; Tökés ZA
Cancer Res; 1985 Jan; 45(1):263-71. PubMed ID: 2578096
[TBL] [Abstract][Full Text] [Related]
12. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
[TBL] [Abstract][Full Text] [Related]
13. Mammary cancer antigen recognized by monoclonal antibody B72.3 in apocrine metaplasia of the human breast.
Castagna M; Nuti M; Squartini F
Cancer Res; 1987 Feb; 47(3):902-6. PubMed ID: 3542197
[TBL] [Abstract][Full Text] [Related]
14. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
Soriano Z; Pardee JD
Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
Dell'Erba L; Calo-Gabrieli G; Caruso ML; Thomas R; Cortino G; Valentini AM; Muto P; Albrizio M; Pastena MI; Lastoria S
Anticancer Res; 2001; 21(2A):925-30. PubMed ID: 11396186
[TBL] [Abstract][Full Text] [Related]
16. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
Shih IM; Nesbit M; Herlyn M; Kurman RJ
Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
[TBL] [Abstract][Full Text] [Related]
17. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
18. Cysteine proteinase inhibitor cystatin A in breast cancer.
Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
[TBL] [Abstract][Full Text] [Related]
19. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a monoclonal antibody reactive with a subset of human breast tumors.
Yuan D; Hendler FJ; Vitetta ES
J Natl Cancer Inst; 1982 May; 68(5):719-28. PubMed ID: 6279951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
